NCT01613677View on ClinicalTrials.gov

Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Treatment for Metastatic or Locally Advanced Cervical Cancer
Interventions
DRUG

BKM120

Trial Locations (1)

20231-050

Novartis Investigative Site, Rio de Janiero

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Novartis Pharmaceuticals

INDUSTRY